Patient and Provider Perspectives on Benefits and Harms of Continuing, Tapering, and Discontinuing Long-Term Opioid Therapy

被引:9
|
作者
Nevedal, Andrea L. [1 ]
Timko, Christine [2 ,3 ]
Lor, Mai Chee [2 ]
Hoggatt, Katherine J. [4 ,5 ]
机构
[1] VA Ctr Clin Management Res, Dept Vet Affairs Hlth Care Syst, Ann Arbor, MI 48105 USA
[2] Ctr Innovat Implementat, Dept Vet Affairs Hlth Care Syst, Palo Alto, CA USA
[3] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA
[4] San Francisco VA Hlth Care Syst, San Francisco, CA USA
[5] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
关键词
opioids; tapering; veterans; patients; providers; qualitative methods; long-term opioid therapy; COMPLEMENTARY;
D O I
10.1007/s11606-022-07880-z
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background Given efforts to taper patients off long-term opioid therapy (LTOT) because of known harms, it is important to understand if patients and providers align in LTOT treatment goals. Objective To investigate patient and provider perceptions about the harms and benefits of continuing and discontinuing LTOT. Design Qualitative study Participants Patients and providers with experiences with LTOT for pain in two Veterans Health Affairs regions. Approach We conducted semi-structured interviews and analyzed data using rapid qualitative analysis to describe patient and provider preferences about LTOT continuation and discontinuation and non-opioid pain treatments. Key Results Participants (n=43) included 28/67 patients and 15/17 providers. When discussing continuing LTOT, patients emphasized the benefits outweighed the harms, whereas providers emphasized the harms. Participants agreed on the benefits of continuing LTOT for improved physical functioning. Provider-reported benefits of continuing LTOT included maintaining the status quo for patients without opioid alternatives or who were at risk for illicit drug use. Participants were aligned regarding the harms of negative side-effects (e.g., constipation) from continued LTOT. In contrast, when discussing LTOT tapering and discontinuation, providers underscored how benefits outweighed the harms, citing patients' improved well-being and pain management with tapering or alternatives. Patients did not foresee benefits to potential LTOT tapers or discontinuation and were worried about pain management in the absence of LTOT. When discussing non-opioid pain treatments, participants emphasized that they were adjunctive to opioid therapy rather than a replacement (except for cannabis). Providers described the importance of mental health services to manage pain, which differed from patients who focused on treatments to improve strength and mobility and reduce pain. Conclusions Patients emphasized the benefits of continuing LTOT for pain management and well-being, which differed from providers' emphasis on the benefits of discontinuing LTOT. Patient and provider differences are important for informing patient-centered care and decisions around continuing, tapering, or discontinuing LTOT.
引用
收藏
页码:1802 / 1811
页数:10
相关论文
共 50 条
  • [41] The Long and the Short of Benzodiazepines and Sleep Medications: Short-Term Benefits, Long-Term Harms?
    Steven T. DeKosky
    John B. Williamson
    Neurotherapeutics, 2020, 17 : 153 - 155
  • [42] The Long and the Short of Benzodiazepines and Sleep Medications: Short-Term Benefits, Long-Term Harms?
    DeKosky, Steven T.
    Williamson, John B.
    NEUROTHERAPEUTICS, 2020, 17 (01) : 153 - 155
  • [43] Long-term benefits of invasive therapy
    Dario Ummarino
    Nature Reviews Cardiology, 2016, 13 (11) : 636 - 636
  • [44] The long-term benefits of endovascular therapy
    Campbell, Bruce C. V.
    Mitchell, Peter J.
    Davis, Stephen M.
    Donnan, Geoffrey A.
    LANCET NEUROLOGY, 2017, 16 (05): : 337 - 338
  • [45] Long-Term PPI Use: Balancing Potential Harms and Documented Benefits
    Laine, Loren
    Nagar, Anil
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (07): : 913 - 915
  • [46] Aspirin in people with dementia, long-term benefits, and harms: a systematic review
    Katrina A. S. Davis
    Delia Bishara
    Mariam Molokhia
    Christoph Mueller
    Gayan Perera
    Robert J. Stewart
    European Journal of Clinical Pharmacology, 2021, 77 : 943 - 954
  • [47] Aspirin in people with dementia, long-term benefits, and harms: a systematic review
    Davis, Katrina A. S.
    Bishara, Delia
    Molokhia, Mariam
    Mueller, Christoph
    Perera, Gayan
    Stewart, Robert J.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (07) : 943 - 954
  • [48] Trends and Rapidity of Dose Tapering Among Patients Prescribed Long-term Opioid Therapy, 2008-2017
    Fenton, Joshua J.
    Agnoli, Alicia L.
    Xing, Guibo
    Hang, Lillian
    Altan, Aylin E.
    Tancredi, Daniel J.
    Jerant, Anthony
    Magnan, Elizabeth
    JAMA NETWORK OPEN, 2019, 2 (11) : e1916271
  • [49] Patient versus Provider Incentives in Long-Term Care
    Hackmann, Martin B.
    Pohl, R. Vincent
    Ziebarth, Nicolas R.
    AMERICAN ECONOMIC JOURNAL-APPLIED ECONOMICS, 2024, 16 (03) : 178 - 218
  • [50] Comparative Effectiveness of Opioid Tapering or Abrupt Discontinuation vs No Dosage Change for Opioid Overdose or Suicide for Patients Receiving Stable Long-term Opioid Therapy
    Larochelle, Marc R.
    Lodi, Sara
    Yan, Shapei
    Clothier, Barbara A.
    Goldsmith, Elizabeth S.
    Bohnert, Amy S. B.
    JAMA NETWORK OPEN, 2022, 5 (08) : E2226523